Reaction Details |
| Report a problem with these data |
Target | Coagulation factor X |
---|
Ligand | BDBM50144126 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_48628 |
---|
IC50 | 8±n/a nM |
---|
Citation | Jia, ZJ; Su, T; Zuckett, JF; Wu, Y; Goldman, EA; Li, W; Zhang, P; Clizbe, LA; Song, Y; Bauer, SM; Huang, W; Woolfrey, J; Sinha, U; Arfsten, AE; Hutchaleelaha, A; Hollenbach, SJ; Lambing, JL; Scarborough, RM; Zhu, BY N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors. Bioorg Med Chem Lett14:2073-8 (2004) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Coagulation factor X |
---|
Name: | Coagulation factor X |
Synonyms: | Activated coagulation factor X (FXa) | Activated factor Xa heavy chain | Coagulation factor X precursor | Coagulation factor Xa | F10 | FA10_HUMAN | Factor X heavy chain | Factor X light chain | Factor Xa | Stuart factor | Stuart-Prower factor |
Type: | Enzyme |
Mol. Mass.: | 54726.60 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 488 |
Sequence: | MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEE
TCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKN
CELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR
KRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQE
CKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGE
AVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGI
VSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSG
GPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPE
VITSSPLK
|
|
|
BDBM50144126 |
---|
n/a |
---|
Name | BDBM50144126 |
Synonyms: | 1-[4-(Azetidin-1-yl-imino-methyl)-benzyl]-4-(5-chloro-1H-indole-2-sulfonyl)-piperazin-2-one | CHEMBL62656 |
Type | Small organic molecule |
Emp. Form. | C23H24ClN5O3S |
Mol. Mass. | 485.986 |
SMILES | Clc1ccc2[nH]c(cc2c1)S(=O)(=O)N1CCN(Cc2ccc(cc2)C(=N)N2CCC2)C(=O)C1 |
Structure |
|